Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00046189 : Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
PhaseN/A
AgesMin: N/A Max: N/A
Eligibility
- INCLUSION CRITERIA:

Members of the XP families where the proband has previously been evaluated at the Clinical
Center or is newly diagnosed under other approved protocols (primarily 99-C-0099) are
eligible to participate in this study. Families with XP patients of any age, gender or
race are eligible for this study.

On referral, families of XP patients will be considered for inclusion in the study if the
proband has clinical documentation of features of XP and laboratory determination of the
DNA repair defect. All relatives of XP patients including spouses are eligible to
participate.

EXCLUSION CRITERIA:

Inability or unwillingness to provide family history information or tissue (skin, blood,
buccal cells or hair) for laboratory studies.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT00046189      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740